NRXCF - NeutriSci International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
432.451
457.75
80.894
74.572
96.538
Cost of Revenue
465.293
501.158
101.441
80.438
93.602
Gross Profit
-32.842
-43.408
-20.547
-5.866
2.936
Operating Expenses
Selling General and Administrative
739.615
596.27
1,323
1,911
1,649
Total Operating Expenses
778.839
646.905
1,368
1,938
1,654
Operating Income or Loss
-811.681
-690.313
-1,388
-1,944
-1,651
Interest Expense
0
0
1
1.382
1.184
Total Other Income/Expenses Net
-104.84
-80.381
-182.981
-6.892
39.765
Income Before Tax
-916.521
-770.694
-1,572
-1,953
-1,613
Income from Continuing Operations
-916.521
-770.694
-1,572
-1,953
-1,613
Net Income
-916.521
-770.694
-1,572
-1,953
-1,613
Net Income available to common shareholders
-916.521
-770.694
-1,572
-1,953
-1,613
Basic EPS
-
-
-
-0.01
-0.01
Diluted EPS
-
-
-
-0.01
-0.01
Basic Average Shares
-
-
-
143,378
116,021
Diluted Average Shares
-
-
-
143,378
116,021
EBITDA
-
-733.431
-1,526
-1,924
-1,607